Opioid Litigation: What's New and What Does It Mean for Future Litigation?
Amid claims that the pharmaceutical industry used misleading tactics to downplay the known harms of prescription opioids, more than 2,000 plaintiffs have joined the largest civil trial in U.S. history: National Prescription Opiate Litigation (MDL 2804). In this symposium, experts discuss the opioid litigation and its effects on the future of mass litigation.
James M. Anderson, Anne Andrews, Sheila Birnbaum, Elizabeth J. Cabraser, Kenneth R. Feinberg, Rebecca Lee Haffajee, Eric Helland, Deborah R. Hensler, Rich Ives, Daniel B. Levin, Charlie Lifland, David Nachman, Robert Reville, Joseph F. Rice, William B. Rubenstein, Christopher A. Seeger